vs
HARROW, INC.（HROW）与READING INTERNATIONAL INC（RDI）财务数据对比。点击上方公司名可切换其他公司
HARROW, INC.的季度营收约是READING INTERNATIONAL INC的1.8倍（$89.1M vs $50.3M），HARROW, INC.净利率更高（7.4% vs -5.1%，领先12.5%），HARROW, INC.同比增速更快（33.3% vs -14.2%），HARROW, INC.自由现金流更多（$8.1M vs $4.1M），过去两年HARROW, INC.的营收复合增速更高（60.5% vs 5.6%）
哈罗健康（前身为Imprimis制药）是一家上市制药企业，总部位于美国田纳西州纳什维尔，深耕制药领域相关业务，在医药研发、生产及商业化方面拥有成熟的运营体系，产品及服务覆盖多个医疗需求场景。
雷丁公司是总部位于美国费城的铁路企业，1924年起在宾夕法尼亚州东部及周边各州提供客运与货运运输服务，直至1976年被联合铁路公司收购。
HROW vs RDI — 直观对比
营收规模更大
HROW
是对方的1.8倍
$50.3M
营收增速更快
HROW
高出47.5%
-14.2%
净利率更高
HROW
高出12.5%
-5.1%
自由现金流更多
HROW
多$4.0M
$4.1M
两年增速更快
HROW
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $89.1M | $50.3M |
| 净利润 | $6.6M | $-2.6M |
| 毛利率 | 79.3% | — |
| 营业利润率 | 17.5% | -1.9% |
| 净利率 | 7.4% | -5.1% |
| 营收同比 | 33.3% | -14.2% |
| 净利润同比 | -2.2% | -14.5% |
| 每股收益（稀释后） | $0.20 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HROWRDI
| Q4 25 | $89.1M | $50.3M | ||
| Q3 25 | $71.6M | $52.2M | ||
| Q2 25 | $63.7M | $60.4M | ||
| Q1 25 | $47.8M | $40.2M | ||
| Q4 24 | $66.8M | $58.6M | ||
| Q3 24 | $49.3M | $60.1M | ||
| Q2 24 | $48.9M | $46.8M | ||
| Q1 24 | $34.6M | $45.1M |
净利润HROWRDI
| Q4 25 | $6.6M | $-2.6M | ||
| Q3 25 | $1.0M | $-4.2M | ||
| Q2 25 | $5.0M | $-2.7M | ||
| Q1 25 | $-17.8M | $-4.8M | ||
| Q4 24 | $6.8M | $-2.2M | ||
| Q3 24 | $-4.2M | $-7.0M | ||
| Q2 24 | $-6.5M | $-12.8M | ||
| Q1 24 | $-13.6M | $-13.2M |
毛利率HROWRDI
| Q4 25 | 79.3% | — | ||
| Q3 25 | 75.3% | — | ||
| Q2 25 | 74.5% | — | ||
| Q1 25 | 67.5% | — | ||
| Q4 24 | 78.8% | — | ||
| Q3 24 | 75.6% | — | ||
| Q2 24 | 74.4% | — | ||
| Q1 24 | 69.5% | — |
营业利润率HROWRDI
| Q4 25 | 17.5% | -1.9% | ||
| Q3 25 | 20.6% | -0.6% | ||
| Q2 25 | 17.9% | 4.8% | ||
| Q1 25 | -23.5% | -17.2% | ||
| Q4 24 | 19.3% | 2.6% | ||
| Q3 24 | 2.7% | -0.6% | ||
| Q2 24 | 3.1% | -16.4% | ||
| Q1 24 | -20.0% | -16.7% |
净利率HROWRDI
| Q4 25 | 7.4% | -5.1% | ||
| Q3 25 | 1.4% | -8.0% | ||
| Q2 25 | 7.8% | -4.4% | ||
| Q1 25 | -37.2% | -11.8% | ||
| Q4 24 | 10.1% | -3.8% | ||
| Q3 24 | -8.6% | -11.7% | ||
| Q2 24 | -13.2% | -27.4% | ||
| Q1 24 | -39.2% | -29.4% |
每股收益（稀释后）HROWRDI
| Q4 25 | $0.20 | $-0.11 | ||
| Q3 25 | $0.03 | $-0.18 | ||
| Q2 25 | $0.13 | $-0.12 | ||
| Q1 25 | $-0.50 | $-0.21 | ||
| Q4 24 | $0.19 | $-0.11 | ||
| Q3 24 | $-0.12 | $-0.31 | ||
| Q2 24 | $-0.18 | $-0.57 | ||
| Q1 24 | $-0.38 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.9M | $10.5M |
| 总债务越低越好 | $250.0M | $185.1M |
| 股东权益账面价值 | $52.4M | $-18.2M |
| 总资产 | $399.5M | $434.9M |
| 负债/权益比越低杠杆越低 | 4.77× | — |
8季度趋势，按日历期对齐
现金及短期投资HROWRDI
| Q4 25 | $72.9M | $10.5M | ||
| Q3 25 | $74.3M | $8.1M | ||
| Q2 25 | $53.0M | $9.1M | ||
| Q1 25 | $66.7M | $5.9M | ||
| Q4 24 | $47.2M | $12.4M | ||
| Q3 24 | $72.6M | $10.1M | ||
| Q2 24 | $71.0M | $9.3M | ||
| Q1 24 | $76.0M | $7.5M |
总债务HROWRDI
| Q4 25 | $250.0M | $185.1M | ||
| Q3 25 | $347.2M | — | ||
| Q2 25 | $250.6M | — | ||
| Q1 25 | $256.9M | — | ||
| Q4 24 | $262.7M | $202.7M | ||
| Q3 24 | $230.7M | — | ||
| Q2 24 | $236.3M | — | ||
| Q1 24 | $243.4M | — |
股东权益HROWRDI
| Q4 25 | $52.4M | $-18.2M | ||
| Q3 25 | $47.0M | $-12.1M | ||
| Q2 25 | $49.7M | $-7.7M | ||
| Q1 25 | $56.5M | $-8.1M | ||
| Q4 24 | $69.7M | $-4.4M | ||
| Q3 24 | $58.0M | $1.6M | ||
| Q2 24 | $58.5M | $6.5M | ||
| Q1 24 | $60.6M | $18.0M |
总资产HROWRDI
| Q4 25 | $399.5M | $434.9M | ||
| Q3 25 | $363.1M | $435.2M | ||
| Q2 25 | $345.0M | $438.1M | ||
| Q1 25 | $364.2M | $441.0M | ||
| Q4 24 | $389.0M | $471.0M | ||
| Q3 24 | $351.5M | $495.7M | ||
| Q2 24 | $306.6M | $494.9M | ||
| Q1 24 | $295.5M | $494.9M |
负债/权益比HROWRDI
| Q4 25 | 4.77× | — | ||
| Q3 25 | 7.39× | — | ||
| Q2 25 | 5.05× | — | ||
| Q1 25 | 4.55× | — | ||
| Q4 24 | 3.77× | — | ||
| Q3 24 | 3.98× | — | ||
| Q2 24 | 4.04× | — | ||
| Q1 24 | 4.02× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.4M | $4.3M |
| 自由现金流经营现金流 - 资本支出 | $8.1M | $4.1M |
| 自由现金流率自由现金流/营收 | 9.1% | 8.2% |
| 资本支出强度资本支出/营收 | 0.4% | 0.3% |
| 现金转化率经营现金流/净利润 | 1.27× | — |
| 过去12个月自由现金流最近4个季度 | $43.0M | $-2.9M |
8季度趋势，按日历期对齐
经营现金流HROWRDI
| Q4 25 | $8.4M | $4.3M | ||
| Q3 25 | $16.6M | $295.0K | ||
| Q2 25 | $-803.0K | $1.6M | ||
| Q1 25 | $19.7M | $-7.7M | ||
| Q4 24 | $-17.8M | $8.0M | ||
| Q3 24 | $3.0M | $1.3M | ||
| Q2 24 | $-2.7M | $-10.4M | ||
| Q1 24 | $-4.6M | $-2.8M |
自由现金流HROWRDI
| Q4 25 | $8.1M | $4.1M | ||
| Q3 25 | $16.4M | $-246.0K | ||
| Q2 25 | $-969.0K | $1.2M | ||
| Q1 25 | $19.5M | $-8.0M | ||
| Q4 24 | $-18.3M | $7.0M | ||
| Q3 24 | $2.3M | $-1.1M | ||
| Q2 24 | $-3.1M | $-10.6M | ||
| Q1 24 | $-4.7M | $-4.7M |
自由现金流率HROWRDI
| Q4 25 | 9.1% | 8.2% | ||
| Q3 25 | 22.9% | -0.5% | ||
| Q2 25 | -1.5% | 1.9% | ||
| Q1 25 | 40.8% | -19.8% | ||
| Q4 24 | -27.4% | 12.0% | ||
| Q3 24 | 4.8% | -1.8% | ||
| Q2 24 | -6.3% | -22.7% | ||
| Q1 24 | -13.6% | -10.4% |
资本支出强度HROWRDI
| Q4 25 | 0.4% | 0.3% | ||
| Q3 25 | 0.3% | 1.0% | ||
| Q2 25 | 0.3% | 0.6% | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 0.8% | 1.7% | ||
| Q3 24 | 1.2% | 4.0% | ||
| Q2 24 | 0.7% | 0.5% | ||
| Q1 24 | 0.3% | 4.3% |
现金转化率HROWRDI
| Q4 25 | 1.27× | — | ||
| Q3 25 | 16.26× | — | ||
| Q2 25 | -0.16× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -2.62× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HROW
暂无分部数据
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
